• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Axsome

Graphic of two hands trying to untangle a thread inside someones head
Biotech

Psychiatry biotech hopes to Transcend PTSD rivals with new data

Transcend Therapeutics's MDMA analog treatment for patients with PTSD displayed rapid and durable effects in a small, open-label trial.
Max Bayer Dec 5, 2023 5:45pm
rocket

Neumora installs new CEO ahead of pivotal depression trials

Jul 18, 2023 6:30am
drawing graphic of a women-presenting person starting off in the distance

Arrivo's depression med flunks ph. 2, shows benefit for women

Oct 17, 2022 12:38pm
pills

Axsome posts positive phase 3 data for depression drug

May 31, 2022 10:41am
Drug inspection FDA regulatory submission

FDA rejects Axsome’s migraine med, but issues are 'addressable'

May 2, 2022 4:21pm
Dementia

Another setback for Axsome as migraine med headed for FDA no

Apr 25, 2022 1:24pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings